Description A blend of Tesamorelin (5mg), MGF (500mcg), and Ipamorelin (2.5mg) studied for its role in regulating growth hormone (GH) secretion and cellular processes. Tesamorelin has been researched for its effects on GH release and lipid metabolism. MGF (Mechano Growth Factor) has been explored for its potential role in cellular signaling and tissue studies. Ipamorelin interacts with the ghrelin receptor, influencing GH secretion while minimizing interactions with other endocrine pathways. This combination is commonly utilized in controlled research settings to evaluate GH-related responses and cellular mechanisms.
